BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 19822369)

  • 21. Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.
    Kovala-Demertzi D; Staninska M; Garcia-Santos I; Castineiras A; Demertzis MA
    J Inorg Biochem; 2011 Sep; 105(9):1187-95. PubMed ID: 21718655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.
    Battistin F; Scaletti F; Balducci G; Pillozzi S; Arcangeli A; Messori L; Alessio E
    J Inorg Biochem; 2016 Jul; 160():180-8. PubMed ID: 26920229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: Production, characterization and in vitro studies.
    Cortesi R; Damiani C; Ravani L; Marvelli L; Esposito E; Drechsler M; Pagnoni A; Mariani P; Sforza F; Bergamini P
    Int J Pharm; 2015 Aug; 492(1-2):291-300. PubMed ID: 26187165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper(II) Schiff base coordination compounds of dien with heterocyclic aldehydes and 2-amino-5-methyl-thiazole: synthesis, characterization, antiproliferative and antibacterial studies. Crystal structure of CudienOOCl2.
    Chaviara AT; Cox PJ; Repana KH; Papi RM; Papazisis KT; Zambouli D; Kortsaris AH; Kyriakidis DA; Bolos CA
    J Inorg Biochem; 2004 Aug; 98(8):1271-83. PubMed ID: 15271502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New water-soluble azido- and derived tetrazolato-platinum(II) complexes with PTA. Easy metal-mediated synthesis and isolation of 5-substituted tetrazoles.
    Smoleński P; Mukhopadhyay S; Guedes da Silva MF; Charmier MA; Pombeiro AJ
    Dalton Trans; 2008 Dec; (46):6546-55. PubMed ID: 19030616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)
    Ceresa C; Nicolini G; Semperboni S; Gandin V; Monfrini M; Avezza F; Alberti P; Bravin A; Pellei M; Santini C; Cavaletti G
    Neurotox Res; 2018 Jul; 34(1):93-108. PubMed ID: 29344837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxorhenium complexes bearing the water-soluble tris(pyrazol-1-yl)methanesulfonate, 1,3,5-triaza-7-phosphaadamantane, or related ligands, as catalysts for Baeyer-Villiger oxidation of ketones.
    Martins LM; Alegria EC; Smoleński P; Kuznetsov ML; Pombeiro AJ
    Inorg Chem; 2013 Apr; 52(8):4534-46. PubMed ID: 23534942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic copper(II), cobalt(II), zinc(II), and nickel(II) coordination compounds of clotrimazole.
    Betanzos-Lara S; Gómez-Ruiz C; Barrón-Sosa LR; Gracia-Mora I; Flores-Álamo M; Barba-Behrens N
    J Inorg Biochem; 2012 Sep; 114():82-93. PubMed ID: 22717722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
    Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
    J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic coordination chemistry and cytotoxicity of copper(II) complexes with methyl substituted 4-nitropyridine N-oxides.
    Puszko A; Brzuszkiewicz A; Jezierska J; Adach A; Wietrzyk J; Filip B; Pełczynska M; Cieslak-Golonka M
    J Inorg Biochem; 2011 Aug; 105(8):1109-14. PubMed ID: 21726775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic activity, X-ray crystal structures and spectroscopic characterization of cobalt(II), copper(II) and zinc(II) coordination compounds with 2-substituted benzimidazoles.
    Sánchez-Guadarrama O; López-Sandoval H; Sánchez-Bartéz F; Gracia-Mora I; Höpfl H; Barba-Behrens N
    J Inorg Biochem; 2009 Sep; 103(9):1204-13. PubMed ID: 19628280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of the water soluble ligands dmPTA and dmoPTA and the complex [RuClCp(HdmoPTA)(PPh(3))](OSO(2)CF(3)) (dmPTA = N,N'-Dimethyl-1,3,5-triaza-7-phosphaadamantane, dmoPTA = 3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane, HdmoPTA = 3,7-H-3,7-Dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane).
    Mena-Cruz A; Lorenzo-Luis P; Romerosa A; Saoud M; Serrano-Ruiz M
    Inorg Chem; 2007 Jul; 46(15):6120-8. PubMed ID: 17580932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One pot synthesis of Cu(II) 2,2'-bipyridyl complexes of 5-hydroxy-hydurilic acid and alloxanic acid: synthesis, crystal structure, chemical nuclease activity and cytotoxicity.
    Dixit N; Koiri RK; Maurya BK; Trigun SK; Höbartner C; Mishra L
    J Inorg Biochem; 2011 Feb; 105(2):256-67. PubMed ID: 21194626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
    Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
    J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, crystal structure and biological activities of a novel amidrazone derivative and its copper(II) complex--a potential antitumor drug.
    Mazur L; Modzelewska-Banachiewicz B; Paprocka R; Zimecki M; Wawrzyniak UE; Kutkowska J; Ziółkowska G
    J Inorg Biochem; 2012 Sep; 114():55-64. PubMed ID: 22694858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylcholine-like and trimethylglycine-like PTA (1,3,5-triaza-7-phosphaadamantane) derivatives for the development of innovative Ru- and Pt-based therapeutic agents.
    Ferretti V; Fogagnolo M; Marchi A; Marvelli L; Sforza F; Bergamini P
    Inorg Chem; 2014 May; 53(10):4881-90. PubMed ID: 24801393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.
    Dolfen D; Schottler K; Valiahdi SM; Jakupec MA; Keppler BK; Tiekink ER; Mohr F
    J Inorg Biochem; 2008 Dec; 102(12):2067-71. PubMed ID: 18707761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
    Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
    J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.